Browsing by Title

Sort by: Order: Results:

  • C 121 inutasyon ve pernisiyöz anemi birlikteliği (Olgu sunumu) 
    Büyükberber, Süleyman; Aydoğdu, İsmet; Uysal, Akın (İnönü Üniversitesi Tıp Fakültesi Dergisi, 1996)
    Bu olgu sunumunda bir vaka nedeniyle li 121 mutasyonlar ile ilgili son literatür gözden geçirilmiş ve il 121 mutasyon ve pernisiyöz anemi birlikteliği ilkkez bildirilmiştir.
  • C şekilli kök kanal yapısına sahip 3 boyutlu model dişlere uygulanan farklı restorasyon tekniklerinin kırılma dayanımlarının değerlendirilmesi 
    ÇETİN, MELİS SILA (İnönü Üniversitesi / Diş Hekimliği Fakültesi / Endodonti Ana Bilim Dalı, 2019)
    Amaç: Bu çalışmada; C şekilli kök kanal yapısına sahip model dişlere uygulanan farklı restorasyon yöntemlerinin kırılma dayanımı üzerine etkisinin incelenmesi amaçlanmaktadır. Materyal ve Metot: Başka nedenlerle çekilmiş ...
  • C-H Bond activation of 2-isobutylthiazole at C5 position catalysed by 
    Bugday, N; Khan, S; Yasar, S; Ozdemir, I (2021)
    A highly efficient and effective protocol has been developed for the synthesis of C5-(hetero)arylated 2-isobutylthiazole derivatives. Four different palladium N-heterocyclic carbene (Pd-NHCs) complexes [Pd(mu-Cl)Cl(SIMes)](2) ...
  • c-Kit proto-oncogene expression in endometrial hyperplasia and 
    Yilmaz, E; Celik, O; Simsek, Y; Turkcuoglu, I; Celik, E; Gul, M; Hascalik, S; Aydin, E (2012)
    To evaluate the expression of c-kit (CD117) in endometrial hyperplasia and endometrial cancer.
  • c-Kit proto-oncogene expression in endometrial hyperplasia and 
    Yilmaz, E; Celik, O; Simsek, Y; Turkcuoglu, I; Celik, E; Gul, M; Hascalik, S; Aydin, E (2012)
    To evaluate the expression of c-kit (CD117) in endometrial hyperplasia and endometrial cancer.
  • C-Kit proto-oncogene expression in endometrial hyperplasia and endometrial cancer 
    Yilmaz, E.; Celik, O.; Simsek, Y.; Turkcuoglu, I.; Celik, E.; Gül, M.; Hascalik, S.; Aydin, E. (2012)
    Purpose To evaluate the expression of c-kit (CD117) in endometrial hyperplasia and endometrial cancer. Methods Expression of c-kit in 10 normal endometrium, 18 simple endometrial hyperplasia, 16 complex endome-trial ...
  • C-reactive protein and aortic stiffness in patients with idiopathic 
    Kosar, F; Aksoy, Y; Ozguntekin, G; Yetkin, E; Gunen, H (E M, 1990,)
    Background: Previous studies have shown an association between C-reactive protein (CRP) and arterial stiffness in most cardiovascular diseases. Increased CRP levels and arterial stiffness have been considered independent ...
  • C-reactive protein and aortic stiffness in patients with idiopathic 
    Kosar, F; Aksoy, Y; Ozguntekin, G; Yetkin, E; Gunen, H (2007)
    Background: Previous studies have shown an association between C-reactive protein (CRP) and arterial stiffness in most cardiovascular diseases. Increased CRP levels and arterial stiffness have been considered independent ...
  • C-reactive protein and aortic stiffness in patients with idiopathic 
    Kosar, F; Aksoy, Y; Ozguntekin, G; Yetkin, E; Gunen, H (2007)
    Background: Previous studies have shown an association between C-reactive protein (CRP) and arterial stiffness in most cardiovascular diseases. Increased CRP levels and arterial stiffness have been considered independent ...
  • C-reactive protein and aortic stiffness in patients with idiopathic 
    Kosar, F; Aksoy, Y; Ozguntekin, G; Yetkin, E; Gunen, H (2007)
    Background: Previous studies have shown an association between C-reactive protein (CRP) and arterial stiffness in most cardiovascular diseases. Increased CRP levels and arterial stiffness have been considered independent ...
  • C-reactive protein and aortic stiffness in patients with idiopathic dilated cardiomyopathy 
    Kosar, F.; Aksoy, Y.; Ozguntekin, G.; Yetkin, E.; Gunen, H. (2007)
    Background: Previous studies have shown an association between C-reactive protein (CRP) and arterial stiffness in most cardiovascular diseases. Increased CRP levels and arterial stiffness have been considered independent ...
  • C-Reactive Protein and Platelet-Lymphocyte Ratio as Potential Tumor 
    Suner, A; Carr, BI; Akkiz, H; Karakulah, G; Uskudar, O; Yalcin, K; Kuran, S; Tokat, Y; Yilmaz, S; Ozakyol, A; Tokmak, S; Balli, T; Yucesoy, M; Bahceci, HI; Ulku, A; Akcam, T; Polat, KY; Ekinci, N; Simsek, H; Ormeci, N; Sonsuz, A; Demir, M; Kilic, M; Uygun, A; Demir, A; Delik, A; Arslan, B; Doran, F; Altintas, E; Temel, T; Bektas, A (2019)
    The hepatocellular carcinoma (HCC) tumor marker alpha-fetoprotein (AFP) is only elevated in about half of the HCC patients, limiting its usefulness in following the effects of therapy or screening. New markers are needed. ...
  • C-Reactive Protein and Platelet-Lymphocyte Ratio as Potential Tumor 
    Suner, A; Carr, BI; Akkiz, H; Karakulah, G; Uskudar, O; Yalcin, K; Kuran, S; Tokat, Y; Yilmaz, S; Ozakyol, A; Tokmak, S; Balli, T; Yucesoy, M; Bahceci, HI; Ulku, A; Akcam, T; Polat, KY; Ekinci, N; Simsek, H; Ormeci, N; Sonsuz, A; Demir, M; Kilic, M; Uygun, A; Demir, A; Delik, A; Arslan, B; Doran, F; Altintas, E; Temel, T; Bektas, A (2019)
    The hepatocellular carcinoma (HCC) tumor marker alpha-fetoprotein (AFP) is only elevated in about half of the HCC patients, limiting its usefulness in following the effects of therapy or screening. New markers are needed. ...
  • C-Reactive Protein and Platelet-Lymphocyte Ratio as Potential Tumor 
    Suner, A; Carr, BI; Akkiz, H; Karakulah, G; Uskudar, O; Yalcin, K; Kuran, S; Tokat, Y; Yilmaz, S; Ozakyol, A; Tokmak, S; Balli, T; Yucesoy, M; Bahceci, HI; Ulku, A; Akcam, T; Polat, KY; Ekinci, N; Simsek, H; Ormeci, N; Sonsuz, A; Demir, M; Kilic, M; Uygun, A; Demir, A; Delik, A; Arslan, B; Doran, F; Altintas, E; Temel, T; Bektas, A (2019)
    The hepatocellular carcinoma (HCC) tumor marker alpha-fetoprotein (AFP) is only elevated in about half of the HCC patients, limiting its usefulness in following the effects of therapy or screening. New markers are needed. ...
  • C-Reactive Protein and Platelet-Lymphocyte Ratio as Potential Tumor 
    Suner, A; Carr, BI; Akkiz, H; Karakulah, G; Uskudar, O; Yalcin, K; Kuran, S; Tokat, Y; Yilmaz, S; Ozakyol, A; Tokmak, S; Balli, T; Yucesoy, M; Bahceci, HI; Ulku, A; Akcam, T; Polat, KY; Ekinci, N; Simsek, H; Ormeci, N; Sonsuz, A; Demir, M; Kilic, M; Uygun, A; Demir, A; Delik, A; Arslan, B; Doran, F; Altintas, E; Temel, T; Bektas, A (2019)
    The hepatocellular carcinoma (HCC) tumor marker alpha-fetoprotein (AFP) is only elevated in about half of the HCC patients, limiting its usefulness in following the effects of therapy or screening. New markers are needed. ...
  • C-reactive protein and platelet-lymphocyte ratio as potential tumor markers in low-alpha-fetoprotein hepatocellular carcinoma 
    Carr, Brian I.; Karakülah, Gökhan (KARGER, ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND, 2018)
    The hepatocellular carcinoma (HCC) tumor marker alpha-fetoprotein (AFP) is only elevated in about half of the HCC patients, limiting its usefulness in following the effects of therapy or screening. New markers are needed. ...
  • C-Reactive protein and platelet-lymphocyte ratio as potential tumor markers in low-alpha-fetoprotein hepatocellular carcinoma 
    Suner, A.; Carr, B.I.; Akkiz, H.; Karakülah, G.; Üsküdar, O.; Yalçln, K.; Kuran, S.; Tokat, Y.; Yilmaz, S.; Özakyol, A.; Tokmak, S.; Balll, T.; Yücesoy, M.; Bahçeci, H.I.; Ülkü, A.; Akçam, T.; Polat, K.Y.; Ekinci, N.; Şimşek, H.; Örmeci, N.; Sonsuz, A.; Demir, M.; Klllç, M.; Uygun, A.; Demir, A.; Delik, A.; Arslan, B.; Doran, F.; Altlntaş, E.; Temel, T.; Bektaş, A. (2018)
    The hepatocellular carcinoma (HCC) tumor marker alpha-fetoprotein (AFP) is only elevated in about half of the HCC patients, limiting its usefulness in following the effects of therapy or screening. New markers are needed. ...
  • C-reactive protein is an indicator for fatal outcomes in first-time 
    Kocer, A; Canbulat, C; Gozke, E; Ilhan, A (2005)
    Background: The causal relation of high sensitivity C-reactive protein (hsCRP) to ischemic cerebrovascular disease remains unclear, though an inflammatory effect has been suggested in many studies. The aim of our study was ...
  • C-reactive protein is an indicator for fatal outcomes in first-time stroke patients 
    Koçer, A.; Canbulat, C.; Gözke, E.; Ilhan, A. (2005)
    Background: The causal relation of high sensitivity C-reactive protein (hsCRP) to ischemic cerebrovascular disease remains unclear, though an inflammatory effect has been suggested in many studies. The aim of our study was ...
  • C-reactive proteinis not an independent risk factor for ventricular thrombus 
    Demirtürk, Orhan Saim; Gülcan, Öner; İsa, Coşkun; Türköz, Rıza (2012)
    Abstract:C-reaktif protein (CRP) yaygın kullanılan ve standart bir akut faz reaktanıdır. Yüksek CRP değerlerinin akut miyokard enfarktüsü, stabil ve anstabil koroner arter hastalığında ileride oluşabilecek olumsuz (advers) ...